Treatment of moderate to severe hidradenitis suppurativa

Comment

Vinay Prasad. Ann Intern Med. 2013.

. 2013 Jul 2;159(1):72.

doi: 10.7326/0003-4819-159-1-201307020-00015.

No abstract available

Comment in

Trust but verify: trial registration and determining fidelity to the protocol.
Zarin DA, Tse T. Zarin DA, et al. Ann Intern Med. 2013 Jul 2;159(1):65-7. doi: 10.7326/0003-4819-159-1-201307020-00011. Ann Intern Med. 2013. PMID: 23817705 No abstract available.
Treatment of moderate to severe hidradenitis suppurativa.
Kimball AB, Gu Y, Okun M. Kimball AB, et al. Ann Intern Med. 2013 Jul 2;159(1):72-3. doi: 10.7326/0003-4819-159-1-201307020-00016. Ann Intern Med. 2013. PMID: 23817710 No abstract available.

Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB. Kimball AB, et al. Ann Intern Med. 2012 Dec 18;157(12):846-55. doi: 10.7326/0003-4819-157-12-201212180-00004. Ann Intern Med. 2012. PMID: 23247938 Clinical Trial.